For information about any of these trials, you may contact the individuals who are listed with each trial or study below, or you may contact us at our general USC MS Comprehensive Care Center number (323-442-6870) or email address (mscare@usc.edu).
Please note that appointments to see our doctors for non-research related care may be made by calling the Weiner Neurology Clinic at 323-442-5710.
Rebif New Formulation Quality of Life Trial
Status:
Close. Study Activities Ongoing
Sponsors:
Serono
Type of Study and Brief Description:
A randomized, multicenter, two-arm, 12 week phase IIIb study to evaluate Quality of Life (QoL) measures in subjects with relapsing forms of Multiple Sclerosis who are transitioning from Rebif® (Interferon beta-1a) to Rebif New Formulation (RNF)
Background:
USC Principal Investigator:
Regina Berkovich, M.D.
Contact:
Jose Aparicio (323-442-6833 or joseapar@usc.edu)
Additional Information:
You can click here for a document that describes more about this trial.
Back to top
|
